🔗 Share this article

This year's Nobel Prize in medical science was awarded for transformative findings that clarify how the body's defense network targets harmful pathogens while sparing the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this honor.

The work identified specialized "sentinels" within the immune system that remove malfunctioning immune cells capable of attacking the body.

The findings are now paving the way for innovative therapies for immune disorders and cancer.

The laureates will share a monetary award valued at 11m SEK.

Crucial Discoveries

"Their research has been essential for understanding how the immune system operates and why we do not all develop serious autoimmune diseases," commented the head of the Nobel Committee.

The team's research address a fundamental mystery: In what way does the defense system defend us from countless infections while leaving our healthy cells intact?

Our immune system employs white blood cells that scan for indicators of infection, even pathogens and bacteria it has never encountered.

These cells employ sensors—known as recognition units—that are generated randomly in countless combinations.

That gives the defense network the capacity to fight a wide array of invaders, but the randomness of the process unavoidably produces immune cells that may target the body.

Security Guards of the Immune System

Scientists previously knew that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells develop.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which patrol the system to neutralize other immune cells that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The prize committee stated, "These findings have established a new field of research and spurred the development of innovative treatments, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells prevent the body from attacking the tumor, so studies are focused on reducing their numbers.

In self-attack disorders, experiments are testing increasing T-reg cells so the organism is not being harmed. A comparable approach could also be useful in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

He showed that introducing defense cells from other mice could prevent the disease—implying there was a system for blocking immune cells from harming the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in mice and humans that resulted in the discovery of a genetic factor vital for how T-regs function.

"The groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, stopping it from accidentally targeting the body's own tissues," said a leading physiology expert.

"The work is a remarkable example of how fundamental biological research can have far-reaching implications for human health."